We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options
A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment
Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more
by Deep Bio
AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target
In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine
A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer
A new molecular test offers the first opportunity to identify the patients who are most likely to benefit from treatment, rather than surveillance
Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?
Discover the latest in pathology and laboratory medicine with this roundup of short news stories
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
Send me the latest from The Pathologist.
by Akoya Biosciences
In this webinar, expert speakers from the Fred Hutchinson Cancer Research Center will discuss how they successfully implemented an automated, multiplexed tissue imaging platform for spatial profiling of the TME.
by Thermo Fisher Scientific
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.